Charles E Koob insider trades: Mimedx Group (MDXG) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Charles reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 13, 2017 | MDXG | ↓ Sell | 50,486 | $8.50 | $429K | Direct | Mar 15, 2017 (2d) |
| Dec 31, 2010 | MDXG | ↑ Buy | 50,486 | $0.99 | $50K | Direct | Jan 4, 2011 (4d) |
| Nov 19, 2009 | MDXG.OB | ↑ Buy | 15,000 | $0.50 | $8K | Direct | Nov 20, 2009 (1d) |
| Oct 19, 2009 | MDXG.OB | ↑ Buy | 16,668 | $0.45 | $8K | Direct | Oct 21, 2009 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Charles E Koob's insider trades
Charles E Koob is a director at Mimedx Group (MDXG). Since Oct 19, 2009, Charles has reported 3 open-market purchases worth $65K and 1 sale worth $429K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (37 filings), option exercises (6 filings), other transactions (5 filings), gifts (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDXG insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.